(Q53301647)

13 May 2018

title

c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin's lymphoma. (English)

1 reference

13 May 2018

author name string

S Aref

1

1 reference

13 May 2018

M Fouda

2

1 reference

13 May 2018

E El-Dosoky

3

1 reference

13 May 2018

A Menessy

4

1 reference

13 May 2018

M Mabed

5

1 reference

13 May 2018

M Saleeb

6

1 reference

13 May 2018

K Zalata

7

1 reference

13 May 2018

publication date

1 June 2003

1 reference

13 May 2018

published in

Hematology

1 reference

13 May 2018

volume

8

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

183-190

1 reference

13 May 2018

Treatment of high-grade lymphoid malignancies in adults

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

The proto-oncogene c-myc in hematopoietic development and leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

A computerized database-scan to identify c-MYC targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

A novel myc target gene, mina53, that is involved in cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

Genes, immunity, and senescence: looking for a link

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

Expression of c-myc p62 Protein in Non-Hodgkin's Lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

Role of the Cdc25A phosphatase in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

Assessment of prognostic factors in follicular lymphoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

Cell cycle activation by c-myc in a burkitt lymphoma model cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

c-MYC overexpression in Ba/F3 cells simultaneously elicits genomic instability and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

Burkitt's acute lymphoblastic leukaemia transformation after myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

cdc25a and the splicing variant cdc25b2, but not cdc25B1, -B3 or -C, are over-expressed in aggressive human non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1024533031000090829

10.1080/1024533031000090829

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018